Product Information
BENZAMYCIN GEL is a brand product labeled by Bausch Health US LLC, priced at $1.2854 per GM under NDC 00187520546. Its NADAC has been published 155 times since Apr 23, 2014.
FDA first approved this application on Oct 26, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Bausch Health US LLCNDC
00187520546
Classification
Brand
Dosage Form
KIT
Effective Date
8/20/2025
Approval Type
New Drug (NDA)
FDA Application
NDA050557FDA Approved
10/26/1984
TE Code
AB
On Market Since
10/26/1984
Price Statistics
The NADAC for BENZAMYCIN GEL has been published 155 times since Apr 23, 2014, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2854 per GM |
|---|---|
| All-time high | $9.3360 (Oct 14, 2015) |
| All-time low | $1.2818 (Apr 17, 2024) |
| Median price | $8.1253 |
| Average price | $5.1262 |
| Largest weekly change | -86.3% (Apr 17, 2024) |
| Weeks tracked | 155 |
| Tracking since | Apr 23, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-86.2%
5Y
-86.2%
All
-84.2%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the erythromycin and benzoyl peroxide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch Health US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
erythromycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZAMYCIN GEL?
The current National Average Drug Acquisition Cost (NADAC) for BENZAMYCIN GEL, manufactured by Bausch Health US LLC, is $1.2854 per GM (NDC 00187520546), effective Oct 1, 2025.
How has the price of BENZAMYCIN GEL changed over time?
Over the history we have for it, the NADAC for BENZAMYCIN GEL has declined 84.2%. It has been tracked across 155 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for BENZAMYCIN GEL?
Since Apr 23, 2014, the NADAC for BENZAMYCIN GEL has ranged from a low of $1.2818 (Apr 17, 2024) to a high of $9.3360 (Oct 14, 2015), with a median of $8.1253 per GM.
Are there cheaper alternatives to BENZAMYCIN GEL?
No other NADAC-published product currently shares the active ingredient and strength of BENZAMYCIN GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENZAMYCIN GEL?
BENZAMYCIN GEL (NDC 00187520546) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.